132 related articles for article (PubMed ID: 31700719)
21. Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge.
Khan AM; Ajmal Z; Raval M; Tobin E
Cureus; 2020 Aug; 12(8):e9629. PubMed ID: 32923230
[TBL] [Abstract][Full Text] [Related]
22. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation.
Chauffaille Mde L; Oliveira JS; Romeo M; Kerbauy J
Sao Paulo Med J; 2001 Jan; 119(1):16-8. PubMed ID: 11175620
[TBL] [Abstract][Full Text] [Related]
24. Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor.
Muñoz JD; Barranco Lampón GI; Castellanos H; Ramos C; Zazueta JF
Cureus; 2019 Jul; 11(7):e5135. PubMed ID: 31523564
[TBL] [Abstract][Full Text] [Related]
25. [18F-fluorodeoxyglucose-positron emission tomography imaging before and after treatment of chronic-phase chronic myeloid leukemia with tyrosine kinase inhibitors].
Oka T; Hirata H; Kitagawa T; Io K; Nagai K
Rinsho Ketsueki; 2020; 61(4):301-304. PubMed ID: 32378570
[TBL] [Abstract][Full Text] [Related]
26. [Acute lymphocytic leukemia with Philadelphia chromosome and rearrangements of bcr gene and deletion of 5' side and of TCR-delta gene].
Ohnishi A; Kagiyama S; Shintate Y; Kimura N; Ohgami A; Takechi M; Tanaka K; Kamada N
Rinsho Ketsueki; 1990 Jun; 31(6):820-6. PubMed ID: 2145450
[TBL] [Abstract][Full Text] [Related]
27. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Hackanson B; Rückert A; Lübbert M
Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
[No Abstract] [Full Text] [Related]
28. The landscape of BCR-ABL mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitors.
Chien SH; Liu HM; Chen PM; Ko PS; Lin JS; Chen YJ; Lee LH; Hsiao LT; Chiou TJ; Gau JP; Yang MH; Liu CY
Hematol Oncol; 2020 Aug; 38(3):390-398. PubMed ID: 32011024
[TBL] [Abstract][Full Text] [Related]
29. Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of 18F-FDG PET/CT.
Su Z; Wu F; Hu W; Liu X; Wu S; Feng X; Cui Z; Yang J; Wang Z; Guan H; Zhao H; Wang W; Zhao C; Peng J
Front Med; 2017 Sep; 11(3):440-444. PubMed ID: 28550639
[TBL] [Abstract][Full Text] [Related]
30. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
[TBL] [Abstract][Full Text] [Related]
31. Detection of BCRabl in Acute Leukemia by Molecular and Cytogenetic Methods.
Wells SJ; Phillips CN; Farhi DC
Mol Diagn; 1996 Dec; 1(4):305-313. PubMed ID: 10462577
[TBL] [Abstract][Full Text] [Related]
32. [Acquisition of Philadelphia chromosome with bcr rearrangement concomitant with transformation of refractory anemia with excess of blasts with 8 trisomy into acute myelogenous leukemia].
Niikura H; Fujita K; Terada H; Haga A; Yamashina A
Rinsho Ketsueki; 1990 Mar; 31(3):335-40. PubMed ID: 2366338
[TBL] [Abstract][Full Text] [Related]
33. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
34. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
[TBL] [Abstract][Full Text] [Related]
35. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
Duan MH; Li H; Cai H
Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
[TBL] [Abstract][Full Text] [Related]
36. Cardiac Tamponade as the Initial Presentation of Acute Myeloid Leukemia: A Case Report with Review of the Literature.
Karmo D; Hafeez A; Halalau A; Yadav S
Case Rep Oncol Med; 2018; 2018():8201917. PubMed ID: 29780652
[TBL] [Abstract][Full Text] [Related]
37. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
38. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.
An X; Tiwari AK; Sun Y; Ding PR; Ashby CR; Chen ZS
Leuk Res; 2010 Oct; 34(10):1255-68. PubMed ID: 20537386
[TBL] [Abstract][Full Text] [Related]
39. Chronic myeloid leukemia presenting with absence of basophils and marked dyspoiesis.
Anand M; Kumar R; Kumar L; Barge S; Singh S
Indian J Cancer; 2003; 40(4):144-7. PubMed ID: 14716111
[TBL] [Abstract][Full Text] [Related]
40. Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia.
Sun J; Wang Z; Luo Y; Tan Y; Allan DS; Huang H
Acta Haematol; 2012; 127(3):143-8. PubMed ID: 22248505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
